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Effects of sex hormones on mesangial cell proliferation and collagen
synthesis. In a variety of renal diseases, males progress at a more rapid
rate and have a more fulminant course than females. This gender
difference may be related to the direct effects of sex hormones on the cells
of the kidney. To evaluate this hypothesis, we studied the effects of
estrogens and testosterone on mesangial cell proliferation and collagen
synthesis. At 48 hours, estradiol at 10 nM and 100 nat had a modest
proliferative effect on cultured mesangial cells, as measured by 3H
thymidine incorporation into DNA and direct cell counting. This estradiol
effect was fully reversed by Tamoxifen (1 rM). Estradiol had no effect on
cellular proliferation at 1 tLM concentrations, but suppressed proliferation
at 10 rM doses. Testosterone had a modest but statistically insignificant
effect on proliferation at 10 nat and 100 nat concentrations but no effect at
I LM or 10 /LM. Neither estradiol nor testosterone at 10 /LM affected total
cellular protein accumulation. Estradiol at I j.M and 10 markedly
suppressed total collagen synthesis as measured by 3H praline incorpora-
tion, and specifically suppressed the synthesis of collagen types I and IV,
as measured by immunoprecipitation and gel electrophoresis. Testoster-
one did not affect collagen synthesis. Estradiol also reduced the steady
state message for the a2 chain of type I collagen, while testosterone had
no effect. Neither estradiol nor testosterone affected the steady state
message for TGF or EGF. The direct effects of estradiol on mesangial
cell collagen generation may help explain the slower development of
glomerulosclerosis in women and therefore the "protective" effect of
female gender on the progression of renal disease.
The progression of various forms of renal disease is more rapid
in men than in women [1, 2]. This has been specifically noted in
membranous nephropathy [3—5], IgA nephropathy [6—8], and
polycystic kidney disease [9, 10]. The specific mechanisms under-
lying this clinical finding are unclear but may be related to the
direct effects of sex hormones on renal tissues. Epidemiological
studies clearly show that female gender is protective against the
development of atherosclerosis, a disease similar in a variety of
ways to glomeruloscierosis. Both atherosclerosis and glomerulo-
sclerosis involve changes in cell biology with deposition of matrix
proteins [11]. In the former case, the smooth muscle cell contrib-
utes to the pathologic changes, and in the latter, the glomerular
mesangial cell. Mesangial cells are similar to smooth muscle cells
of the vascular wall, both structurally and functionally [12].
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Therefore, factors such as gender, which affect the development
of atherosclerosis, may affect glomerulosclerosis by similar mech-
anisms.
Considerable information exists regarding the direct effects of
estrogens and testosterone on smooth muscle cells of the vascu-
lature. Studies show that estradiol suppresses collagen synthesis in
cultured vascular smooth muscle cells [13]. In vivo, estrogen
administration reduces the accumulation of collagen and elastin
in the aortae of normal, hypertensive and cholesterol-fed animals
[14—16]. In addition, female gender or administration of estradiol
are both associated with increased collagen degradation in rat
aortae and connective tissue [17, 18]. Testosterone administration
or oophorectomy has the opposite effects [15, 16, 19]. These direct
effects of sex hormones have been used to explain the protective
effect of female gender on the development of atherosclerosis.
Given the direct effects of sex hormones on the vasculature, the
similarity between cells of the vasculature and mesangial cells, and
the contribution of gender to the progression of renal disease, we
evaluated the direct effects of estradiol and testosterone on
mesangial cell biology. We report that estradiol affects mesangial
cell proliferation and suppresses the generation of collagen.
Methods
Rat mesangial cell culture
Male Sprague-Dawley rats, 75 to 100 g, (Charles River, Wil-
mington, MA, USA) were anesthetized and bilateral nephrecto-
mies performed. After mincing of the cortical tissue, glomeruli
were isolated by differential sieving, and mesangial cells cultured
by standard techniques [20]. For the experiments, cells were used
between the ninth and fifteenth passages. Cultured mesangial cells
between these passages all had similar morphology, similar repli-
cation rate and response to proliferative agents.
Protein synthesis
Total protein was evaluated in cells exposed to estradiol or
testosterone for specified times. Cell layers were then solubilized
with 1 N NaOH and the Biorad protein assay (Biorad, Richmond,
CA, USA) performed using bovine serum albumin as standard.
The assay was constructed to be linear for protein concentrations
between 10 pg/100 jd and 120 /.LgIlOO pi. Proteins were assessed
in triplicate and the mean of triplicate samples served as a single
experimental point in a given experiment.
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Cellular proliferation
Cellular proliferation was assessed by the incorporation of 3H
thymidine into cellular DNA, and by cell counts of the trypsinized
cell layers. For the thymidine incorporation experiments, rat
mesangial cells were cultured into 96 well plates at a concentra-
tion of 40,000 cells/mI. RPMI media (Gibco Laboratories, Grand
Island, NY, USA), containing 10% FBS and 1% penicillin!
streptomycin solution (Sigma), was changed every two to three
days and on the day of the experiment, changed to that containing
charcoal-stripped fetal bovine serum (5%) (Gibco). Charcoal
stripped FBS was used since FBS may contain small amounts of
estrogens and testosterone. Estradiol or testosterone (1 nM to 10
MM) was added to the cells for a total of 48 hours. Hormone
concentrations were chosen based on published studies using sex
hormones in tissue culture [13]. For the final 24 hours of the
incubation, 3H thymidine (Amersham, Arlington Heights, IL,
USA) was added at a concentration of 2 1xCi/ml. At the end of the
incubation periods, cell layers were extensively washed with
phosphate buffered saline (PBS), the cells exposed to trypsin!
EDTA (Gibco) for 30 minutes, and harvested using a cell
harvester (PHD cell harvester; Cambridge Technologies, Water-
town, MA, USA). The incorporation of 3H thymidine into DNA
was assessed by liquid scintillation counting. All experiments were
done in triplicate wells, and the means of the triplicate determi-
nations served as a single experimental point for an individual
experiment. For the corresponding experiments using absolute
cell counts, a Neubauer hemocytometer (Clay Adams, NY, USA)
was used.
Collagen synthesis
Radiolabeled pro/me incorporation. The synthesis of collagen by
mesangial cells incubated with estradiol or testosterone was
evaluated by assessing 3H proline incorporation into collagenase
sensitive protein. Cultured mesangial cells (plated at 40,000
cells/ml) were incubated for 48 hours with either control proline-
free DMEM medium or proline-free medium containing estradiol
(10 /xM) or testosterone (10 /LM) in the presence of 3H proline (15
1xCi!ml) (NEN/Dupont, Boston, MA, USA), /3-amino propion-
itrile (/3-APN), a collagen cross-link inhibitor (80 xg/ml; Sigma
Chemical, St. Louis, MO, USA) [2fl, and ascorbic acid (50 xg!ml;
Sigma). At the end of the incubation period, the medium,
containing secreted, non-crosslinked collagen and other proteins
was collected and precipitated with ethanol containing 3% BSA
(4°C, overnight). The precipitated samples were then centrifuged
(2000 RPM X 10 mm) and the pellet resuspended in 50 m Tris
buffer containing CaCI2 (1 mM) and N-ethylmaleimide (4 mM).
The samples were digested with 10 to 20 units of collagenase
depending on well size. (type VII, Sigma) for 90 minutes at 37°C.
The treated mixture was then precipitated with TCA (4°C). The
collagenase sensitive material was not precipitable by the TCA
step, and therefore remained in the supernatant. Aliquots of the
supernatant were then used for liquid scintillation counting. The
pellet containing collagenasc insensitive material was resus-
pended and counted. We have determined that 83 to 88% of the
protein that incorporated 3H proline was collagenase sensitive
[201. We have also determined, by amino acid analysis, that the
collagenase sensitive material generated by this method is indeed
collagen [201.
Immunoprecipitation. Mesangial cells were grown as described
earlier and exposed to either estradiol (1 nM, 10 nM, 1 MM, 10 MM),
testosterone (1 nM, 10 flM, 1 MM, 10 MM) or control media for 12,
24 or 48 hours, in the presence of ascorbic acid (50 pg/mI),
/3-aminopropionitrile (80 jxg/ml), and 3H proline (15 MCi/mI).
Aliquots of the culture medium were collected and mixed with
equal volumes of 'RIPA' buffer consisting of 50 mtvi Tris (pH 7.5),
150 mM NaCl, 0.1% SDS, 1% Triton X-100, 0.5% deoxycholate
and 1 mivi PMSF (Sigma). Normal goat serum was added followed
by a 10% suspension of protein A-positive staphylococcus aureus
(Boehringer Mannheim Biochem, Indianapolis, IN, USA). This
mixture was incubated on a rocker for one hour at 4°C. Non-
specifically bound material was removed by centrifugation for 10
minutes at 5,000 RPM. Collagens, remaining in the supernatant
after centrifugation, were specifically precipitated using goat
antibody against human and bovine type I or IV collagen (South-
ern Biotechnology Associates, Inc.), depending upon the specific
experiment. After one hour of incubation, rabbit antigoat anti-
body and the protein A suspension were added and the immuno-
precipitates recovered by centrifugation. The resulting pellet was
washed three times with cold RIPA buffer and then resuspended
in Laemmle sample buffer by boiling (2 mm). This suspension was
then run on a 7.5% SDS polyacrylamide gel. The resulting bands
were enhanced by autoradiography [20].
Messenger RNA for collagen I, TGF-/3 and EGF
The steady state messages for the cx2 chain of procollagen type
I and epidermal growth factor (EGF) were evaluated by dot blot
analysis. Mesangial cells were grown as described above and
exposed to either estradiol, testosterone or control media for 48
hours. After extraction of total RNA [22], 100 g aliquots were
dissolved in diethylpyrocarbonate-treated water and a mixture of
formaldehyde and 20 x SSC in equal volumes. This solution was
heated for 15 minutes at 65°C in order to denature the RNA. The
material was then dot blotted at various concentrations onto
riitrocellulose membranes by using a Bio-Rad dot blot apparatus.
The blotted membranes were heated at 80°C for 1.5 hours. The
human collagen I cDNA probe [231 or mouse EGF probe [24]
(Oncogene Science) were prepared by the Rad-Prime Kit (B.R.L)
using 25 ng of DNA. The probes were heated for five minutes at
100°C and kept on ice prior to use. Pre-hybridization and hybrid-
ization of the labeled probe with the RNA fixed to the nitrocel-
lulose filter was accomplished in a solution of SDS, termanide,
Denhardt, 20 X SSPE (all from Sigma) and H20 at 42°C.
Prehybridization was done for 1.5 hours and hybridization was
accomplished overnight. After hybridization, the filters were
washed twice in 2>< SSC and 0.1% SDS at room temperature and
then with 0.2 SSC and 0.1% SDS at 55°C for 45 minutes. Filters
were then autoradiographed using an intensifying screen [25, 261.
Filters were stripped with a solution consisting of Tris-HCI (5
mM), EDTA (2 mM), and 0.lx Denhardt solution, and re-probed
with GAPDH [27] to correct for variations in RNA loading.
The steady state message for TGF/3 [281 was determined by
Northern analysis after mesangial cells were grown as described
above and exposed to either estradiol, testosterone or control
media for 48 hours. After extraction of total RNA [221, 10 g
aliquots of the extract were loaded, run on a 1% agarose gel, and
transferred to nylon filters [291. Labeling of the eDNA probe was
accomplished by random-prime transcription using 32P-dCTP
[26]. Nylon filters were prehybridized (65°C, 1 to 3 hr) in a
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solution containing I M NaCI and 1% SDS and then hybridized
with the labeled eDNA probe for 16 hours. After the filters were
washed to high stringency, autoradiography with intensifying
screens (170°C) was performed. Hybridization of the specific
mRNAs was quantitated by laser densitometry. Hybridization for
GAPDH was used to normalize for any differences in RNA
loading.
Results
Estradiol (10 nM) increased mesangial cell proliferation to
124.1 3% control values, while testosterone had a slight but
statistically insignificant effect (N = 4; Fig. 1). At 100 nM
concentrations (N = 3), estradiol increased mesangial cell prolif-
eration to 123.2 4% control. Testosterone increased prolifera-
tion to 113.8 5% control, but this was not statistically significant.
Lower concentrations of either estradiol or testosterone (1 nM)
had no effect on cellular proliferation (P = NS, N = 4 experi-
ments). Tamoxifen (1 jiM) completely reversed the proliferative
effect of estradiol at 10 nM, and had no effect on cell proliferation
alone (103.5 12% control; N = 6). Although no effect of
proliferation was seen in response to either estradiol or testoster-
one at 1 jiM concentrations, estradiol at 10 jiM significantly
suppressed proliferation (67.4 4% control; Fig. 1). In contrast,
testosterone had no significant effect. Direct cell counts confirmed
the increase in proliferation in response to 10 nM estradiol, and
the decrease in proliferation in response to 10 jiM estradiol. At 10
TiM concentrations the control was 28 7, estradiol was 46 2,
and testosterone was 40 9 X i0 cells/ml SEM. At 10 jiM
concentrations the control was 53 4, estradiol was 38 2, and
testosterone was 50 6 )< iO cells/mI SEM (N 4). Trypan
blue exclusion confirmed the viability of cells treated with 10 /.LM
estradiol. In addition, detachment of cells from their substrata was
evaluated after 48 hours of hormone exposure and no differences
were seen between the groups. Since phenol red, or a contaminant
associated with phenol red present in RPM! culture medium, has
been shown to have estrogenic effects in certain tissues [30j, we
conducted the aforementioned proliferation experiments using
phenol red-free RPM! as well as the standard RPM! medium
containing phenol red at a concentration of 5 mg/100 ml. No
differences were detected between these two groups of experi-
ments, establishing that the phenol present in our lot of RPM! did
CoIl Cal IV
Control 2863.0 26.8 5367.0 258.1
Estradiol (10 /LM) 1523.5 90.9° 3677.5 613.4°
Testosterone (10 jiM) 2608.0 188.8 5713.5 1037.0
not have any detectable estrogenic effects on mesangial cell
proliferation.
The Biorad assay was used to measure total cellular protein in
mesangial cell cultures exposed to estradiol (10 jiM) or testoster-
one (10 jiM) for 12 hours, 24 hours, or 48 hours. Despite a
reduction in cell number in cultures exposed to estradiol (10 jiM)
for 48 hours compared to cultures exposed to either control media
or testosterone, cell protein levels were no different between the
conditions (control, 2.6 0.4; estradiol, 2.5 0.4; testosterone,
2.3 0.4 mg/plate SCM, N = 3). In addition, little change in total
cellular protein occurred over the 48 hours of observation.
Figure 2 shows the effect of estradiol (10 j.LM) on 3H proline
incorporation into collagenase sensitive protein (total collagen).
At 10 jiM, estradiol (48 hr) suppressed total collagen synthesis by
mesangial cells by approximately 30% compared to control cul-
tures. In contrast, testosterone (10 jiM), had no significant effect
on total collagen synthesis at this concentration. In addition,
neither estradiol nor testosterone affected the incorporation of 3H
prolinc into non-collagenase sensitive protein (non-collagen pro-
teins) (data not shown). Aliquots of collagen, synthesized in
response to estradiol or testosterone, were immunoprecipitated
prior to gel electrophoresis and the counts shown in Table 1.
Estradiol (10 jiM, 48 hr) significantly suppressed both type I and
type IV collagen synthesis. Although not shown in Table 1,
estradiol at 1 jIM concentration also suppressed type I collagen
synthesis, hut to a lesser degree (18.1 1.2% reduction) com-
pared to control cultures (P < 0.05). Estradiol at I nM and 10 nM
did not affect collagen I synthesis. In these studies, testosterone
did not significantly affect type I or IV collagen synthesis at 1 ntvt,
10 nM, 1 j.LM or 10 jiM concentrations.
An example of autoradiography of immunoprecipitated and
150
0
1 nM lOnM lOOnM 1 IIM 10 p.M
Fig. I. 3H thymidine incorporation into DNA in response to I nM, 10 ni'l,
100 nM, 1 jiM or 10 jiM of estradiol () or testosterone () at 48 hours. *P <
0.05 v. control.
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Fig. 2. Total collagen synthesis measured by 3j proline incorporation into
collagenase Sensitive protein after 48 hours incubation with control media or
media containing hormone (10 jiM). Data are presented as % of control
values. Abbreviations are: Estrad, estradiol (10 jiM); Testo, testosterone
(10 jiM); *p < 0.01 vs. control.
Table 1. 3H-collagen, (CPM/min sCM)
Control Estrad 10 p.M Testo 10 p.M
Abbreviations are: CoIl, immunoprecipitatcd collagen type 1; Col IV,
immunoprecipitated collagen type IV.
P < 0.05 vs. control
I a
e
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Fig. 3. A. Immunoprecipitable collagen type I
after 48 hours incubation with control media or
hormone and 3H proline. B. Immunoprecipitable
collagen type IV after 48 hours incubation with
control media or hormone and 3H proline.
Abbreviations are: C, control; E2, estradiol (10
sM); T, testosterone (10 tLM).
Time hours C E, T
12 950 104 913 285 938 187
24 1092±25 1102± 114 1140± 46
48 1971 84 1443 188 1908 382
Abbreviations are: C, control; E2, estradiol (10 sM); T, testosterone (10
/.LM).
up < 0.05 vs. C.
electrophoresed samples of collagen types I and IV generated
after 48 hours incubation with control media or that containing
either estradiol or testosterone (10 xM), and the labeled precursor
3H proline, is shown in Figure 3 A and B, respectively. The
synthesis of both collagen types I and IV were suppressed by
estradiol compared with control cultures. Testosterone had no
apparent effect on the synthesis of either of these collagens.
Collagen I synthesis increased over time as shown in Table 2.
However, the effect of estradiol (10 ILM) on suppressing the
synthesis of collagen type I was not evident until 48 hours.
To evaluate whether estradiol or testosterone affected tran-
scription of the collagen I gene, dot blot analysis was performed.
Figure 4 shows the densitometry values for mRNA levels of
collagen I in mesangial cells exposed to control media or that
containing estradiol or testosterone (1 /xM for 48 hr). Estradiol
significantly suppressed the steady state message for the a2 chain
100
0
(1)0
60
of procollagen type 1. Testosterone had no detectable effect on
this message.
To evaluate whether estradiol's action on collagen synthesis
might be mediated by EGF or TGF-p, dot blot and Northern blot
analyses were performed after RNA extraction from mesangial
cells exposed to hormone at either I /xM or 10 xM concentrations
for 48 hours. Estradiol had no significant effect on the steady state
message for EGF (1 ILM) (relative densitometry units corrected
for GAPDH SEM: control, 1.00; estradiol, 1.08 0.13; testos-
terone, 1.01 0.18; P = NS,N = 3). In addition, the steady state
Table 2. Immunoprecipitated collagen type I (CPM/min 5EM)
40
Fig. 4. Dot blot densitometiy readings of mRNA for the a2 chain of
procollagen 1. Abbreviations are: Estrad, estradiol; Testo, testosterone.
N = 3; * < 0.01 vs. control.
E210pU EI pU C(lO) C(I) TIOiiU TI MU
TGF 0 p .eaea — tS
GAPOH —'4
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Fig. 5. Northern blot of mRNA fbr TGF/3 in
1 .4 cells grown in control media or hormone for 48
hours. Abbreviations are: C(1), control for I /LM
dose hormone; C(10), control for 10 M dose
hormone; E2, estradiol; T, testosterone.
message for TGFI3 (N = 3) was unchanged by estradiol or
testosterone at both /.tM and 10 j.tM concentrations as shown in
a representative Northern blot (Fig. 5).
Discussion
Observations in experimental animals and in humans have
shown that the rate of progression of renal disease is influenced by
gender. Deterioration of renal function in patients with chronic
renal disease is more rapid in men than women, independent of
differences in blood pressure or serum cholesterol levels [1, 2, 6,
31]. In various experimental models of renal injury, manipulation
of the hormonal milieu can replicate the effects of gender on the
course of renal disease [32, 331. These observations suggest that
sex hormones per se, rather than genetically-determined differ-
ences between the sexes in renal structure, are primarily respon-
sible for the greater susceptibility of the male kidney to progres-
sive renal injury. Sex hormones may influence many of the
processes implicated in the pathogenesis of renal disease progres-
sion, including cell proliferation and the synthesis and degrada-
tion of collagen and proteoglycans. In addition, sex hormones may
indirectly influence these processes by modulating the synthesis
and release of vasoactive agents, cytokines and other growth
factors which in turn are capable of altering mesangial cell
function. Thus, the impact of gender on renal disease progression
may reflect receptor-mediated direct effects of sex hormones on
renal tissue. Our study demonstrates that sex hormones influence
mesangial cell proliferation and collagen generation. Since cellu-
lar proliferation and collagen accumulation may contribute to
progressive glomerular injury, direct effects of sex hormones on
these processes may help explain gender-related differences in
renal disease progression.
If the impact of gender on renal disease progression is mediated
through direct effects of sex hormones, then receptors for these
hormones must exist in the kidney. Estrogen and testosterone
receptors have been detected in whole kidney, kidney sections and
kidney tubules in various animal species [34—37]. In addition, we
have recently reported that cultured rat mesangial cells from male
rats contain nuclear receptors for both estradiol and testosterone
[38]. Female rats were not studied and therefore we do not know
if mesangial cells from these animals have different numbers of
receptors for estradiol or testosterone, or respond differently to
these hormones.
The cellular effects of sex hormones are tissue and organ
specific. In osteoblasts [39], female reproductive organs [40] and
renal proximal tubular epithelium from hamsters, but not in rats
or mice [41], estradiol has been found to be mainly pro-prolifer-
ative, while in cells with characteristics similar to mesangial cells
(smooth muscle and fibroblasts), estradiol has no detectible
mitogenic effect [13, 42]. These effects seem to be dependent not
only on cell or tissue type, but also on the specific culture and
incubation conditions of the individual experiments performed.
Androgens have been shown to be either pro- or antiproliferative
depending on cell type and culture conditions [43—45]. In our
studies of cultured rat mesangial cells, estradiol at 10 n and 100
nM concentrations increased cellular proliferation, but at higher
doses (10 JLM) suppressed proliferation. The action of 10 nM
estradiol on stimulating mesangial cell proliferation was receptor
mediated since tamoxifen reversed the effect. Testosterone, at 10
n and 100 nM concentrations, had a tendency to increase cellular
proliferation but this did not reach statistical signficance. At I
or 10 /LM doses, testosterone had no effect. Despite the ability to
suppress cellular proliferation at 10 /.LM concentrations, estradiol
did not significantly affect total cell protein content compared to
control cultures or those receiving testosterone. It appears that
the estradiol-treated cells contained more protein than those in
the control or testosterone treated groups. This effect was not
visible using conventional inverted phase microscopy. The upper
end of the range of sex hormone concentrations used in our in
vitro experiments is greater than that commonly found circulating
in vivo in the rat (approximately 0.3 to 3 nM) [46] or mid-cycle in
pre-menopausal women (estradiol, approximately 2 nM) [47]. The
tissue levels of these hormones achieved in rats or premenopausal
women, however, is unknown.
We found that estradiol suppressed total collagen synthesis by
mesangial cells, as evaluated by 3H proline incorporation into
collagenase sensitive protein. Specifically, the synthesis of both
collagen types I and IV was reduced in cell culture. The reduction
in collagen synthesis seen in estradiol treated cells cannot be
explained by reduced cell number since, estradiol at 1 !.LM
concentrations had no effect on cell number but significantly
reduced type I collagen synthesis. In cultured vascular smooth
muscle cells, which bear similarities in structure and function to
cultured mesangial cells, estradiol suppresses collagen synthesis
[13]. In vivo, estrogen reduces the synthesis and accumulation of
collagen and elastin in the vascular wall of rats [15], in aortae of
rats fed an atherogenic diet [16], and in hypertensive rats [14]. In
contrast, testosterone appears to increase the accumulation of
collagen and elastin in the aortae of normal or cholesterol fed
animals [15, 19]. The ability of estradiol to suppress collagen
synthesis by cultured mesangial cells may serve as protection
against increased glomerular collagen deposition in various forms
D
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of renal disease. However, net collagen accumulation is deter-
mined by the balance of collagen synthesis and degradation, and
further studies are necessary to determine the effect of sex
hormones on collagen degradation. While estradiol and female
gender are associated with increased collagen degradation in
vascular smooth muscle cells and connective tissue [18, 48], data
in the kidney are conflicting [49, 50].
Our measurements of steady state levels of mRNA for collagen
type I show transcriptional regulation by estradiol. At I xM
concentrations, estradiol suppressed collagen I mRNA levels in
mesangial cells. This concentration of hormone also resulted in
diminished type I collagen synthesis. In contrast, testosterone had
no significant effect on the steady state message level for the a2
chain of collagen I or on the synthesis of collagen I. Information
regarding transcriptional regulation of collagen genes by steroid
hormones is limited, but it has been shown that steroids suppress
collagen gene activity in skin fibroblasts [51]. Specific regulation of
collagen genes by the sex hormones, estradiol and testosterone,
has not been studied in detail. Sex hormones however, do affect
the activity of various proto-oncogenes, including c-fos and c-fun,
whose products contribute to the AP-1 complex [52, 53]. It is
known that AP- 1 binding sites are present on the first intron of the
human ol collagen gene [54], as well as on the collagenase
promoter [55]. Since sex hormones induce expression of onco-
genes that may regulate collagen gene expression, it is possible
that sex hormones may affect transcription of matrix genes
through these intermediaries.
In nonrenal cell types, sex hormones stimulate the synthesis of
various cytokines known to affect the synthesis of collagen, such as
TGF and EGF. For example, estradiol increases the synthesis
and release of TGF and EGF in cell lines derived from various
female reproductive organs [56—59]. In renal tissue, the ability of
estradiol to enhance the synthesis of these cytokines is poorly
worked out, but these agent are known to affect matrix production
[60, 61]. Our studies do not support a role for TGF/3 in the
suppression of collagen I mRNA by estradiol in cultured mesan-
gial cells, since TGFj3 mRNA levels were not reduced on exposure
to estradiol. However, levels of TGFJ3 were not specifically
measured in our studies, and it is possible that levels of active
TGFI3 may have been reduced despite no change in mRNA levels.
In addition, no change in the steady state message for EGF was
detected in response to estradiol.
The studies reported here, point to a direct effect of sex
hormones on mesangial cell collagen synthesis. The differential
effect of estradiol and testosterone on collagen synthesis by
mesangial cells may help explain why renal injury progresses more
rapidly in men than in women.
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